GB1518683A - Pharmaceutical compositions - Google Patents
Pharmaceutical compositionsInfo
- Publication number
- GB1518683A GB1518683A GB28246/75A GB2824675A GB1518683A GB 1518683 A GB1518683 A GB 1518683A GB 28246/75 A GB28246/75 A GB 28246/75A GB 2824675 A GB2824675 A GB 2824675A GB 1518683 A GB1518683 A GB 1518683A
- Authority
- GB
- United Kingdom
- Prior art keywords
- july
- skin permeation
- alkaloid
- ergot
- dissolved
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
Landscapes
- Health & Medical Sciences (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH931274 | 1974-07-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1518683A true GB1518683A (en) | 1978-07-19 |
Family
ID=4350618
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB28246/75A Expired GB1518683A (en) | 1974-07-05 | 1975-07-04 | Pharmaceutical compositions |
Country Status (14)
Country | Link |
---|---|
JP (1) | JPS5132724A (es) |
AU (1) | AU8280175A (es) |
BE (1) | BE831042A (es) |
DE (1) | DE2528516A1 (es) |
ES (1) | ES439113A1 (es) |
FR (1) | FR2276832A1 (es) |
GB (1) | GB1518683A (es) |
HU (1) | HU170215B (es) |
IL (1) | IL47634A (es) |
NL (1) | NL7507798A (es) |
NZ (1) | NZ178011A (es) |
SE (1) | SE7507414L (es) |
YU (1) | YU170475A (es) |
ZA (1) | ZA754304B (es) |
Cited By (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4751087A (en) * | 1985-04-19 | 1988-06-14 | Riker Laboratories, Inc. | Transdermal nitroglycerin delivery system |
US4752612A (en) * | 1983-07-01 | 1988-06-21 | Nitto Electrical Industrial Co., Ltd. | Method and percutaneously administering physiologically active agents using an alcohol adjuvant and a solvent |
GB2230444A (en) * | 1989-04-19 | 1990-10-24 | Ritchie Swanson John | Topical therapeutic compositions containing betaine surfactant |
US5059427A (en) * | 1987-05-15 | 1991-10-22 | Sansho Co., Ltd. | Pharmaceutical preparation for percutaneous administration containing eperisone or tolperisone or salt thereof |
US5128376A (en) * | 1983-07-01 | 1992-07-07 | Nitto Denko Corporation | Method for percutaneously administering physiologically active agents using an adjuvant a solvent and a diol moderator |
US5219877A (en) * | 1989-09-25 | 1993-06-15 | Bristol-Myers Squibb Company | Lauryl alcohol as skin penetration enhancer for topical imidazole agents |
US5223261A (en) * | 1988-02-26 | 1993-06-29 | Riker Laboratories, Inc. | Transdermal estradiol delivery system |
US5652228A (en) * | 1993-11-12 | 1997-07-29 | The Procter & Gamble Company | Topical desquamation compositions |
US5681852A (en) * | 1993-11-12 | 1997-10-28 | The Procter & Gamble Company | Desquamation compositions |
US5807820A (en) * | 1988-05-13 | 1998-09-15 | Novartis Ag | Cyclosporin compositions for topical application |
US5821237A (en) * | 1995-06-07 | 1998-10-13 | The Procter & Gamble Company | Compositions for visually improving skin |
US6005135A (en) * | 1996-03-21 | 1999-12-21 | Exxon Chemical Patents Inc. | Water-borne polymeric vehicle for coating compositions containing an amine or ammonium salt of phenolic ester alcohols |
EP1011610A1 (en) * | 1997-08-15 | 2000-06-28 | Scandinavian-American Import/Export Corporation | Skin care compositions and use |
EP2223703A1 (en) * | 2007-11-22 | 2010-09-01 | Medrx Co., Ltd. | External preparation composition comprising fatty acid-based ionic liquid as active ingredient |
EP2570115A1 (en) * | 2011-09-13 | 2013-03-20 | Nitto Denko Corporation | Composition for enhancing transdermal absorption of a drug and patch preparation |
EP2570116A1 (en) * | 2011-09-13 | 2013-03-20 | Nitto Denko Corporation | Composition for enhancing transdermal absorption of a drug and patch preparation |
US9526763B2 (en) | 2005-02-03 | 2016-12-27 | Intarcia Therapeutics Inc. | Solvent/polymer solutions as suspension vehicles |
US9539200B2 (en) | 2005-02-03 | 2017-01-10 | Intarcia Therapeutics Inc. | Two-piece, internal-channel osmotic delivery system flow modulator |
US9572889B2 (en) | 2008-02-13 | 2017-02-21 | Intarcia Therapeutics, Inc. | Devices, formulations, and methods for delivery of multiple beneficial agents |
US9682127B2 (en) | 2005-02-03 | 2017-06-20 | Intarcia Therapeutics, Inc. | Osmotic delivery device comprising an insulinotropic peptide and uses thereof |
US9724293B2 (en) | 2003-11-17 | 2017-08-08 | Intarcia Therapeutics, Inc. | Methods of manufacturing viscous liquid pharmaceutical formulations |
US9889085B1 (en) | 2014-09-30 | 2018-02-13 | Intarcia Therapeutics, Inc. | Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c |
USD835783S1 (en) | 2016-06-02 | 2018-12-11 | Intarcia Therapeutics, Inc. | Implant placement guide |
US10159714B2 (en) | 2011-02-16 | 2018-12-25 | Intarcia Therapeutics, Inc. | Compositions, devices and methods of use thereof for the treatment of cancers |
US10231923B2 (en) | 2009-09-28 | 2019-03-19 | Intarcia Therapeutics, Inc. | Rapid establishment and/or termination of substantial steady-state drug delivery |
USD860451S1 (en) | 2016-06-02 | 2019-09-17 | Intarcia Therapeutics, Inc. | Implant removal tool |
US10501517B2 (en) | 2016-05-16 | 2019-12-10 | Intarcia Therapeutics, Inc. | Glucagon-receptor selective polypeptides and methods of use thereof |
US10527170B2 (en) | 2006-08-09 | 2020-01-07 | Intarcia Therapeutics, Inc. | Osmotic delivery systems and piston assemblies for use therein |
US10835580B2 (en) | 2017-01-03 | 2020-11-17 | Intarcia Therapeutics, Inc. | Methods comprising continuous administration of a GLP-1 receptor agonist and co-administration of a drug |
US10925639B2 (en) | 2015-06-03 | 2021-02-23 | Intarcia Therapeutics, Inc. | Implant placement and removal systems |
US11246913B2 (en) | 2005-02-03 | 2022-02-15 | Intarcia Therapeutics, Inc. | Suspension formulation comprising an insulinotropic peptide |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS54163810A (en) * | 1978-06-14 | 1979-12-26 | Mundipharma Ag | Gel composition for local coating |
JPS56159310A (en) * | 1980-05-14 | 1981-12-08 | Showa Denko Kk | Preparation of monofilament having high strength and knot strength |
FR2483235A1 (fr) * | 1980-05-28 | 1981-12-04 | Fabre Sa Pierre | Compositions a usage topique contenant des alcaloides de l'ergot de seigle et de vinca rosea destinees au traitement des hyperseborrhees |
JPS59216825A (ja) * | 1983-05-23 | 1984-12-06 | Takeda Chem Ind Ltd | 経皮吸収外用製剤 |
US4590190A (en) * | 1983-07-01 | 1986-05-20 | Nitto Electric Industrial Co., Ltd. | Method for percutaneously administering physiologically active agents using an alcohol adjuvant and a solvent |
JPS6013720A (ja) * | 1983-07-01 | 1985-01-24 | Nitto Electric Ind Co Ltd | 生理的活性剤の吸収促進剤 |
JPH0735331B2 (ja) * | 1986-01-16 | 1995-04-19 | 久光製薬株式会社 | 外用ゲル製剤 |
JPH0735332B2 (ja) * | 1986-02-25 | 1995-04-19 | 久光製薬株式会社 | 外用クリ−ム製剤 |
JPH0759519B2 (ja) * | 1987-02-23 | 1995-06-28 | 株式会社資生堂 | 経皮吸収促進剤及びこれを含有する皮膚外用製剤 |
US4746515A (en) * | 1987-02-26 | 1988-05-24 | Alza Corporation | Skin permeation enhancer compositions using glycerol monolaurate |
DE3710216A1 (de) * | 1987-03-27 | 1988-10-06 | Rentschler Arzneimittel | Verwendung von dihydroergotamin und seinen salzen zur lokalen behandlung trophischer stoerungen |
ATE164080T1 (de) * | 1990-05-10 | 1998-04-15 | Bechgaard Int Res | Pharmazeutische zubereitung enthaltend n- glykofurole und n-äthylenglykole |
US5397771A (en) * | 1990-05-10 | 1995-03-14 | Bechgaard International Research And Development A/S | Pharmaceutical preparation |
IL98747A0 (en) * | 1991-07-05 | 1992-07-15 | Yissum Res Dev Co | Ophthalmic compositions |
NZ513441A (en) † | 1999-02-08 | 2004-01-30 | Alza Corp | Stable non-aqueous single phase viscous drug delivery vehicles comprising a polymer a solvent and a surfactant |
US7258869B1 (en) | 1999-02-08 | 2007-08-21 | Alza Corporation | Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle |
JP2012020991A (ja) | 2010-06-16 | 2012-02-02 | Takasago Internatl Corp | 経皮吸収促進剤、及びこれを含有する皮膚外用製剤 |
EP3213769A4 (en) | 2014-10-30 | 2018-02-21 | Asahi Kasei Kabushiki Kaisha | Transdermal-absorption-promoter and transdermal-absorption-promoting supplement |
-
1975
- 1975-06-26 DE DE19752528516 patent/DE2528516A1/de active Pending
- 1975-06-27 SE SE7507414A patent/SE7507414L/xx unknown
- 1975-07-01 NL NL7507798A patent/NL7507798A/xx unknown
- 1975-07-02 YU YU01704/75A patent/YU170475A/xx unknown
- 1975-07-03 HU HUSA2816A patent/HU170215B/hu unknown
- 1975-07-03 ES ES439113A patent/ES439113A1/es not_active Expired
- 1975-07-03 IL IL47634A patent/IL47634A/xx unknown
- 1975-07-03 FR FR7520946A patent/FR2276832A1/fr active Granted
- 1975-07-03 NZ NZ178011A patent/NZ178011A/xx unknown
- 1975-07-04 JP JP50082022A patent/JPS5132724A/ja active Pending
- 1975-07-04 BE BE158022A patent/BE831042A/xx unknown
- 1975-07-04 GB GB28246/75A patent/GB1518683A/en not_active Expired
- 1975-07-04 ZA ZA754304A patent/ZA754304B/xx unknown
- 1975-07-07 AU AU82801/75A patent/AU8280175A/en not_active Expired
Cited By (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4752612A (en) * | 1983-07-01 | 1988-06-21 | Nitto Electrical Industrial Co., Ltd. | Method and percutaneously administering physiologically active agents using an alcohol adjuvant and a solvent |
US5128376A (en) * | 1983-07-01 | 1992-07-07 | Nitto Denko Corporation | Method for percutaneously administering physiologically active agents using an adjuvant a solvent and a diol moderator |
US4751087A (en) * | 1985-04-19 | 1988-06-14 | Riker Laboratories, Inc. | Transdermal nitroglycerin delivery system |
US5059427A (en) * | 1987-05-15 | 1991-10-22 | Sansho Co., Ltd. | Pharmaceutical preparation for percutaneous administration containing eperisone or tolperisone or salt thereof |
US5073375A (en) * | 1987-05-15 | 1991-12-17 | Sansho Co., Ltd. | Pharmaceutical preparation for percutaneous administration containing eperisone or tolperisone or salt thereof |
US5223261A (en) * | 1988-02-26 | 1993-06-29 | Riker Laboratories, Inc. | Transdermal estradiol delivery system |
US5807820A (en) * | 1988-05-13 | 1998-09-15 | Novartis Ag | Cyclosporin compositions for topical application |
GB2230444B (en) * | 1989-04-19 | 1993-12-08 | Ritchie Swanson John | Therapeutic compositions. |
GB2230444A (en) * | 1989-04-19 | 1990-10-24 | Ritchie Swanson John | Topical therapeutic compositions containing betaine surfactant |
US5219877A (en) * | 1989-09-25 | 1993-06-15 | Bristol-Myers Squibb Company | Lauryl alcohol as skin penetration enhancer for topical imidazole agents |
US5652228A (en) * | 1993-11-12 | 1997-07-29 | The Procter & Gamble Company | Topical desquamation compositions |
US5681852A (en) * | 1993-11-12 | 1997-10-28 | The Procter & Gamble Company | Desquamation compositions |
US5849728A (en) * | 1993-11-12 | 1998-12-15 | The Procter & Gamble Company | Desquamation compositions |
US5821237A (en) * | 1995-06-07 | 1998-10-13 | The Procter & Gamble Company | Compositions for visually improving skin |
US6005135A (en) * | 1996-03-21 | 1999-12-21 | Exxon Chemical Patents Inc. | Water-borne polymeric vehicle for coating compositions containing an amine or ammonium salt of phenolic ester alcohols |
EP1011610A1 (en) * | 1997-08-15 | 2000-06-28 | Scandinavian-American Import/Export Corporation | Skin care compositions and use |
EP1011610A4 (en) * | 1997-08-15 | 2004-08-18 | Scandinavian American Imp Exp | SKIN CARE COMPOSITIONS AND THEIR USE |
US9724293B2 (en) | 2003-11-17 | 2017-08-08 | Intarcia Therapeutics, Inc. | Methods of manufacturing viscous liquid pharmaceutical formulations |
US9539200B2 (en) | 2005-02-03 | 2017-01-10 | Intarcia Therapeutics Inc. | Two-piece, internal-channel osmotic delivery system flow modulator |
US10363287B2 (en) | 2005-02-03 | 2019-07-30 | Intarcia Therapeutics, Inc. | Method of manufacturing an osmotic delivery device |
US11246913B2 (en) | 2005-02-03 | 2022-02-15 | Intarcia Therapeutics, Inc. | Suspension formulation comprising an insulinotropic peptide |
US9682127B2 (en) | 2005-02-03 | 2017-06-20 | Intarcia Therapeutics, Inc. | Osmotic delivery device comprising an insulinotropic peptide and uses thereof |
US9526763B2 (en) | 2005-02-03 | 2016-12-27 | Intarcia Therapeutics Inc. | Solvent/polymer solutions as suspension vehicles |
US10527170B2 (en) | 2006-08-09 | 2020-01-07 | Intarcia Therapeutics, Inc. | Osmotic delivery systems and piston assemblies for use therein |
US8623387B2 (en) | 2007-11-22 | 2014-01-07 | Medrx Co., Ltd. | External preparation composition comprising fatty acid-based ionic liquid as active ingredient |
CN103239721B (zh) * | 2007-11-22 | 2016-03-16 | 美德阿利克斯株式会社 | 包括基于脂肪酸的离子型液体作为活性成分的外用制剂组合物 |
CN101909651B (zh) * | 2007-11-22 | 2013-11-06 | 美德阿利克斯株式会社 | 包括基于脂肪酸的离子型液体作为活性成分的外用制剂组合物 |
EP2223703A4 (en) * | 2007-11-22 | 2011-01-19 | Medrx Co Ltd | EXTERNAL PREPARATION COMPOSITION COMPRISING FATTY ACID-BASED IONIC LIQUID AS ACTIVE INGREDIENT |
AU2008327436B2 (en) * | 2007-11-22 | 2013-09-05 | Medrx Co., Ltd. | External preparation composition comprising fatty acid-based ionic liquid as active ingredient |
EP2223703A1 (en) * | 2007-11-22 | 2010-09-01 | Medrx Co., Ltd. | External preparation composition comprising fatty acid-based ionic liquid as active ingredient |
US9572889B2 (en) | 2008-02-13 | 2017-02-21 | Intarcia Therapeutics, Inc. | Devices, formulations, and methods for delivery of multiple beneficial agents |
US10441528B2 (en) | 2008-02-13 | 2019-10-15 | Intarcia Therapeutics, Inc. | Devices, formulations, and methods for delivery of multiple beneficial agents |
US12042557B2 (en) | 2009-09-28 | 2024-07-23 | I2O Therapeutics, Inc. | Rapid establishment and/or termination of substantial steady-state drug delivery |
US10231923B2 (en) | 2009-09-28 | 2019-03-19 | Intarcia Therapeutics, Inc. | Rapid establishment and/or termination of substantial steady-state drug delivery |
US10869830B2 (en) | 2009-09-28 | 2020-12-22 | Intarcia Therapeutics, Inc. | Rapid establishment and/or termination of substantial steady-state drug delivery |
US10159714B2 (en) | 2011-02-16 | 2018-12-25 | Intarcia Therapeutics, Inc. | Compositions, devices and methods of use thereof for the treatment of cancers |
US9707189B2 (en) | 2011-09-13 | 2017-07-18 | Nitto Denko Corporation | Composition for enhancing transdermal absorption of a drug and patch preparation |
US9707187B2 (en) | 2011-09-13 | 2017-07-18 | Nitto Denko Corporation | Composition for enhancing transdermal absorption of a drug and patch preparation |
EP2570116A1 (en) * | 2011-09-13 | 2013-03-20 | Nitto Denko Corporation | Composition for enhancing transdermal absorption of a drug and patch preparation |
EP2570115A1 (en) * | 2011-09-13 | 2013-03-20 | Nitto Denko Corporation | Composition for enhancing transdermal absorption of a drug and patch preparation |
US9889085B1 (en) | 2014-09-30 | 2018-02-13 | Intarcia Therapeutics, Inc. | Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c |
US10583080B2 (en) | 2014-09-30 | 2020-03-10 | Intarcia Therapeutics, Inc. | Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c |
US10925639B2 (en) | 2015-06-03 | 2021-02-23 | Intarcia Therapeutics, Inc. | Implant placement and removal systems |
US11214607B2 (en) | 2016-05-16 | 2022-01-04 | Intarcia Therapeutics Inc. | Glucagon-receptor selective polypeptides and methods of use thereof |
US11840559B2 (en) | 2016-05-16 | 2023-12-12 | I2O Therapeutics, Inc. | Glucagon-receptor selective polypeptides and methods of use thereof |
US10501517B2 (en) | 2016-05-16 | 2019-12-10 | Intarcia Therapeutics, Inc. | Glucagon-receptor selective polypeptides and methods of use thereof |
USD840030S1 (en) | 2016-06-02 | 2019-02-05 | Intarcia Therapeutics, Inc. | Implant placement guide |
USD912249S1 (en) | 2016-06-02 | 2021-03-02 | Intarcia Therapeutics, Inc. | Implant removal tool |
USD962433S1 (en) | 2016-06-02 | 2022-08-30 | Intarcia Therapeutics, Inc. | Implant placement guide |
USD860451S1 (en) | 2016-06-02 | 2019-09-17 | Intarcia Therapeutics, Inc. | Implant removal tool |
USD835783S1 (en) | 2016-06-02 | 2018-12-11 | Intarcia Therapeutics, Inc. | Implant placement guide |
US10835580B2 (en) | 2017-01-03 | 2020-11-17 | Intarcia Therapeutics, Inc. | Methods comprising continuous administration of a GLP-1 receptor agonist and co-administration of a drug |
US11654183B2 (en) | 2017-01-03 | 2023-05-23 | Intarcia Therapeutics, Inc. | Methods comprising continuous administration of exenatide and co-administration of a drug |
Also Published As
Publication number | Publication date |
---|---|
IL47634A (en) | 1978-07-31 |
YU170475A (en) | 1984-02-29 |
JPS5132724A (es) | 1976-03-19 |
FR2276832A1 (fr) | 1976-01-30 |
ES439113A1 (es) | 1977-10-16 |
DE2528516A1 (de) | 1976-01-22 |
FR2276832B1 (es) | 1978-10-06 |
ZA754304B (en) | 1977-02-23 |
SE7507414L (sv) | 1976-01-07 |
NZ178011A (en) | 1978-07-28 |
BE831042A (fr) | 1976-01-05 |
AU8280175A (en) | 1977-01-13 |
NL7507798A (nl) | 1976-01-07 |
HU170215B (es) | 1977-04-28 |
IL47634A0 (en) | 1975-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1518683A (en) | Pharmaceutical compositions | |
UA29406C2 (uk) | Складні ефіри трициклічних аміноспиртів | |
MX9205046A (es) | 1h-imidazo-(4,5-c)quinolin-4-aminas 1-substituidas | |
BR9407910A (pt) | Composto composiçao farmacêutica uso do composto processo de tratamento de distúrbios no sistema nervoso central e processo de preparaçao do composto | |
MY121908A (en) | 3-amidopyrazole derivatives, process for preparing these and pharmaceutical compositions containing them. | |
DE69531741D1 (de) | Verbindungen und zusammensetzungen zur verabreichung aktiver stoffe | |
HUP0000589A2 (hu) | Vizes peptid készítmények | |
BG102254A (en) | Oral fast soluble compositions as dopamine antagonists | |
MY103943A (en) | Orthorhombic ciclosporin crystal form, process for its production and pharmaceutical compositions containing it | |
YU47116B (sh) | Postupak za dobijanje novih n-supstituisanih benzimidazolskih derivata | |
MY102929A (en) | Aqueous pharmaceutical formulations of piroxicam monohydrate | |
ATE226428T1 (de) | Verfahren zur herstellung von pharmazeutischen zusammensetzungen | |
KR930001903A (ko) | 유비데카레논 경구용 수용액 제제 | |
ES450075A1 (es) | Un metodo de preparacion de derivados de bis-triazinilamino-estilbeno. | |
ATE139446T1 (de) | Arzneimittel zur behandlung von erregungszuständen und nervendysfunktionen | |
ATE14437T1 (de) | Aminoglycosid-derivate, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische zusammensetzungen und solche derivate zur verwendung als arzneimittel. | |
GB1314926A (en) | Urea-derivatives | |
GB1183299A (en) | Foam Bath Compositions | |
SE9302006D0 (sv) | Protein formulation | |
JPS5251362A (en) | Preparation of optically active pyrrolidine derivatives | |
GB1353834A (en) | Benzenesulphonamides | |
GB1291414A (en) | Aerosol composition | |
JPH10251139A (ja) | 液状冷感浴用剤 | |
GB1315275A (en) | Insecticide | |
JPS6416712A (en) | Hair tonic |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CSNS | Application of which complete specification have been accepted and published, but patent is not sealed |